These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16006513)

  • 1. Modulation of epithelial neoplasia and lymphoid hyperplasia in PTEN+/- mice by the p85 regulatory subunits of phosphoinositide 3-kinase.
    Luo J; Sobkiw CL; Logsdon NM; Watt JM; Signoretti S; O'Connell F; Shin E; Shim Y; Pao L; Neel BG; Depinho RA; Loda M; Cantley LC
    Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10238-43. PubMed ID: 16006513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase.
    Chagpar RB; Links PH; Pastor MC; Furber LA; Hawrysh AD; Chamberlain MD; Anderson DH
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5471-6. PubMed ID: 20212113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of phosphoinositide 3-kinase regulatory isoforms in development and actin rearrangement.
    Brachmann SM; Yballe CM; Innocenti M; Deane JA; Fruman DA; Thomas SM; Cantley LC
    Mol Cell Biol; 2005 Apr; 25(7):2593-606. PubMed ID: 15767666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted biallelic inactivation of Pten in the mouse prostate leads to prostate cancer accompanied by increased epithelial cell proliferation but not by reduced apoptosis.
    Ma X; Ziel-van der Made AC; Autar B; van der Korput HA; Vermeij M; van Duijn P; Cleutjens KB; de Krijger R; Krimpenfort P; Berns A; van der Kwast TH; Trapman J
    Cancer Res; 2005 Jul; 65(13):5730-9. PubMed ID: 15994948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compound heterozygosity for Pten and SHIP augments T-dependent humoral immune responses and cytokine production by CD(4+) T cells.
    Moody JL; Jirik FR
    Immunology; 2004 Jul; 112(3):404-12. PubMed ID: 15196208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased insulin sensitivity in mice lacking p85beta subunit of phosphoinositide 3-kinase.
    Ueki K; Yballe CM; Brachmann SM; Vicent D; Watt JM; Kahn CR; Cantley LC
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):419-24. PubMed ID: 11752399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interplay Among PI3K/AKT, PTEN/FOXO and AR Signaling in Prostate Cancer.
    Yan Y; Huang H
    Adv Exp Med Biol; 2019; 1210():319-331. PubMed ID: 31900915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous disruption of the PTEN promotes intestinal neoplasia in APCmin/+ mouse: roles of osteopontin.
    Shao J; Washington MK; Saxena R; Sheng H
    Carcinogenesis; 2007 Dec; 28(12):2476-83. PubMed ID: 17693663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
    Blando J; Portis M; Benavides F; Alexander A; Mills G; Dave B; Conti CJ; Kim J; Walker CL
    Am J Pathol; 2009 May; 174(5):1869-79. PubMed ID: 19395652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of PI3K-Akt signaling pathway promotes prostate cancer cell invasion.
    Shukla S; Maclennan GT; Hartman DJ; Fu P; Resnick MI; Gupta S
    Int J Cancer; 2007 Oct; 121(7):1424-32. PubMed ID: 17551921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
    Fang J; Ding M; Yang L; Liu LZ; Jiang BH
    Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics.
    Zhong H; Chiles K; Feldser D; Laughner E; Hanrahan C; Georgescu MM; Simons JW; Semenza GL
    Cancer Res; 2000 Mar; 60(6):1541-5. PubMed ID: 10749120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism.
    Palian BM; Rohira AD; Johnson SA; He L; Zheng N; Dubeau L; Stiles BL; Johnson DL
    PLoS Genet; 2014 Dec; 10(12):e1004789. PubMed ID: 25502566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The p85beta regulatory subunit of PI3K serves as a substrate for PTEN protein phosphatase activity during insulin mediated signaling.
    He J; de la Monte S; Wands JR
    Biochem Biophys Res Commun; 2010 Jul; 397(3):513-9. PubMed ID: 20515662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
    Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
    Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between synaptogenesis and the PTEN phosphatase expression in dendrites during postnatal brain development.
    Perandones C; Costanzo RV; Kowaljow V; Pivetta OH; Carminatti H; Radrizzani M
    Brain Res Mol Brain Res; 2004 Sep; 128(1):8-19. PubMed ID: 15337313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Male-biased effects of gonadotropin-releasing hormone neuron-specific deletion of the phosphoinositide 3-kinase regulatory subunit p85alpha on the reproductive axis.
    Acosta-Martínez M; Luo J; Elias C; Wolfe A; Levine JE
    Endocrinology; 2009 Sep; 150(9):4203-12. PubMed ID: 19541766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
    Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
    Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Divergent roles of the regulatory subunits of class IA PI3K.
    Kim CW; Lee JM; Park SW
    Front Endocrinol (Lausanne); 2023; 14():1152579. PubMed ID: 38317714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphoinositide 3-kinase pathway activation in phosphate and tensin homolog (PTEN)-deficient prostate cancer cells is independent of receptor tyrosine kinases and mediated by the p110beta and p110delta catalytic subunits.
    Jiang X; Chen S; Asara JM; Balk SP
    J Biol Chem; 2010 May; 285(20):14980-14989. PubMed ID: 20231295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.